Events & Training

SMi’s 22nd Annual Pain Therapeutics Conference

04 May 2022 - 05 May 2022

Conference Chairman: Richard Malamut, Chief Medical Officer, Collegium Pharmaceutical, Inc Novel Compounds and Treatments for Pain: Opioids and the Alternatives SMi’s 22nd Pain Therapeutics Conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the latest advancements in the field, highlighting the use of opioids and the future for cannabinoids within the pain therapeutics field. Furthermore, policy experts will provide an essential regulatory perspective for this year’s agenda, providing an exciting and comprehensive insight into the pain therapeutics market.

Copthorne Tara Hotel, Kensington, London

Evolution Summit

09 May 2022 - 11 May 2022

The Evolution Summit is an invitation-only, premium Summit bringing leading clinical trial executives and innovative suppliers and solution providers together. The Summit’s content is aligned with key clinical trial challenges and interests, relevant market developments, and practical and progressive ideas and strategies adopted by successful pioneers.

Encore Boston Harbor, Boston MA, USA

Highly Potent Active Pharmaceutical Ingredients

09 May 2022 - 10 May 2022

Sponsored by: BIA Separations | eTheRNA Immunotherapies | Thermo Fisher Scientific Bolstering the latest advances and opportunities in RNA-based medicine The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing vaccines against COVID-19 in response to the global pandemic. This year’s conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development.

London UK

LSX World Congress - Rescheduled

10 May 2022 - 11 May 2022

The LSX World Congress is back returning live in London on 10 - 11 May 2022! It gathers the founders and CEOs of innovative start-ups through to publicly healthcare giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future. The biotech, healthtech and medtech industry’s c-suite will be joined by the sector’s most active investors, pharma and health technology BD&L teams, R&D leaders, KOLs and top tier service companies who are driving the sector forward. Find out more at #LSXWorld

133 Houndsditch, Liverpool St. London

SMi’s 4th Annual Conference Injectable Drug Delivery

11 May 2022 - 12 May 2022

As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use of long-release injectable compounds. There is a rising demand for vaccines, insulin, and many modern medicines used to treat cancer and other chronic diseases. As biologics are mainly administered through the injectable route, the significant growth in the biologics market is expected to drive the injectable drug delivery and prefilled syringe market in the coming years. The injectable drug delivery market is expected to rise at a compound annual growth rate of 12.9% reaching £915 billion by 2027. This year’s event will highlight innovations within the industry with regard to injectable device design and the formulation challenges of long-lasting, highly viscous and high volume drug delivery. There will be an additional focus on the impact that covid has had on advances within this industry over the past year. The conference will also highlight the significance of sustainability within the injectable drug delivery industry, whilst providing regulatory insight on the changes that have occurred.

St James' Court, Buckingham Gate, London, United Kingdom